about
Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugsHigh sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles.Glyconanoparticles as multifunctional and multimodal carbohydrate systems.Synthesis and evaluation of fluorescent Pam3Cys peptide conjugates.Structural Characterization of Biofunctionalized Gold Nanoparticles by Ultrahigh-Resolution Mass SpectrometryMultivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells.Enhanced glycan nanoprofiling by weak anion exchange preparative chromatography, mild acid desialylation, and nanoliquid chromatography-mass spectrometry with nanofluorescence detection.A quantitative study of the intracellular dynamics of fluorescently labelled glyco-gold nanoparticles via fluorescence correlation spectroscopy.STD NMR study of the interactions between antibody 2G12 and synthetic oligomannosides that mimic selected branches of gp120 glycans.Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN.Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas.Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles.Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses.Gold Nanoparticles as Carriers for Synthetic Glycoconjugate VaccinesThe Core Fucose on an IgG Antibody is an Endogenous Ligand of Dectin-1Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cellsSynthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody InteractionNovel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung MicrobiotaGold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine
P50
Q30401180-E48CB605-A95F-4DCD-A66F-2684E1EE37A8Q33829799-370D28BB-D727-4E58-AA3D-73D196D6C73EQ34981074-61B38683-8932-441B-A7D0-F4193F0F1B7DQ38071545-AB8CF690-BFF8-410D-809D-BE686BC7F6E5Q38764971-BBCFB4FB-7FCB-4A08-8445-CD46F82C1160Q41669643-3732A81F-790B-47BE-9CE3-4111554CFF28Q42288763-47915AD8-FB3D-4198-83FE-5F099C543C84Q43697777-EF4CDA8E-A3C7-4E80-8F9E-3F3C148BFBB2Q44973390-3E11F3DF-BD53-4D7B-A6B4-60C0F9224478Q45244200-89CBB5E5-E980-4391-9DA5-6F0019D63398Q46963802-EA7AAF39-6FD3-430A-847A-7170FDD3F484Q53241411-74531165-2C77-42BF-86D5-BA03173A0D78Q53395484-238A94AD-F7F0-4AB6-BCD1-3BFA29715F1CQ53831012-49C603C9-965D-41E2-9D28-3014AE155F2FQ57266944-25DDA75E-BEDD-48C5-A8CD-4707200914BEQ90789909-ED5A3EFF-B2B9-49CA-B932-EB2AA516A13AQ91071766-C5A30C65-129A-4965-8D15-2C06F58F95AFQ93089173-1337A626-C02E-49C1-B5A0-F8F6443C1EDEQ95603251-1BE55629-7F7A-4B81-932A-AF8028A6AD8CQ95812278-3717DE79-BFD4-49A3-A896-47AA11F5C270
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabrizio Chiodo
@ast
Fabrizio Chiodo
@en
Fabrizio Chiodo
@es
Fabrizio Chiodo
@nl
Fabrizio Chiodo
@sl
type
label
Fabrizio Chiodo
@ast
Fabrizio Chiodo
@en
Fabrizio Chiodo
@es
Fabrizio Chiodo
@nl
Fabrizio Chiodo
@sl
altLabel
F. Chiodo
@nl
prefLabel
Fabrizio Chiodo
@ast
Fabrizio Chiodo
@en
Fabrizio Chiodo
@es
Fabrizio Chiodo
@nl
Fabrizio Chiodo
@sl
P1053
R-1121-2017
P106
P1153
51260932900
P21
P2798
P31
P3829
P496
0000-0003-3619-9982
P735
P7449
PRS1331755